Caribou Biosciences

Caribou Biosciences(CRBU)

BERKELEY, CA
Biotechnology2 H-1B visas (FY2023)

Focus: Cellular Engineering Tools (CRISPR)

Caribou Biosciences is a life sciences company focused on Cellular Engineering Tools (CRISPR).

Gene Therapy
Funding Stage
PUBLIC
Open Jobs
3

Pipeline & Clinical Trials

Caribou-sponsored investigational therapy
Lymphoma, Non-Hodgkin
N/A
Clinical Trials (1)
NCT05332054Long-Term Follow-up Study
N/A
Clinical Trials (1)
NCT04637763CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER)
Phase 1
Clinical Trials (1)
NCT05722418CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma
Phase 1
Clinical Trials (1)
NCT06128044CRISPR-Edited Allogeneic Anti-CLL-1 CAR-T Cell Therapy in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Phase 1
Clinical Trials (1)
NCT06752876CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy, in Patients With Refractory Systemic Lupus Erythematosus (GALLOP)
Phase 1

Open Jobs (3)

Interview Prep Quick Facts
Founded: 2015
Portfolio: 5 clinical trials
H-1B (2023): 2 approvals
SEC Filings: 2 available
Open Roles: 3 active jobs

Financials (FY2025)

Revenue
$10M71%
R&D Spend
$130M(1302%)16%
Net Income
-$149M
Cash
$16M

Hiring Trend

Stable
3
Open Roles
+0
Added
-0
Filled/Removed

Based on last 4 crawl cycles

Visa Sponsorship

Sponsors Work Visas
H-1B Petitions (FY2023)
2
Approved
0
Denied
100%
Rate

Source: USCIS H-1B Employer Data Hub